« Honda Accord Plug-In Hybrid on sale at select New York and California dealerships | Main | Pike Research forecasts smart city technology market to grow to $20.2B annually in 2020; smart transportation component to be worth $5.5B by 2020 »
New metabolic engineering tool for microbial cell factories for chemicals, fuels and materials
22 January 2013
A South Korean research team led by Sang Yup Lee at the Korea Advanced Institute of Science and Technology (KAIST) has developed a new metabolic engineering tool to construct efficiently microbial cell factories producing desired chemicals, fuels and materials. The new tool allows fine control of gene expression level by employing synthetic small regulatory RNAs; a paper on the work is published in the journal Nature Biotechnology.
Biotechnologists have been working to develop sustainable processes for the production of chemicals, fuels and materials from renewable non-food biomass. One promising technology is the use of microbial cell factories for the efficient production of desired chemicals and materials.
When microorganisms are isolated from nature, their performance in producing desired products is rather poor. Metabolic engineering is performed to improve the metabolic and cellular characteristics to achieve enhanced production of desired product at high yield and productivity. Since the performance of microbial cell factory is very important in lowering the overall production cost of the bioprocess, many different strategies and tools have been developed for the metabolic engineering of microorganisms.
One of the big challenges in metabolic engineering is to find the best platform organism and to find those genes to be engineered so as to maximize the production efficiency of the desired chemical. Even Escherichia coli, the most widely utilized simple microorganism, has thousands of genes, the expression of which is highly regulated and interconnected to finely control cellular and metabolic activities. Thus, the complexity of cellular genetic interactions is beyond our intuition and thus it is very difficult to find effective target genes to engineer.
Together with gene amplification strategy, gene knockout strategy has been an essential tool in metabolic engineering to redirect the pathway fluxes toward our desired product formation. However, experimenting to engineer many genes can be rather difficult due to the time and effort required; for example, a gene deletion experiment can take a few weeks depending on the microorganisms.
Furthermore, as certain genes are essential or play important roles for the survival of a microorganism, gene knockout experiments cannot be performed. Moreover, there are many different microbial strains one can employ. There are more than 50 different E. coli strains that metabolic engineers can consider. Since gene knockout experiments are hard-coded (that is, one should repeat the gene knockout experiments for each strain), the result cannot be easily transferred from one strain to another.
The paper addresses this issue and suggests a new strategy for identifying gene targets to be knocked out or knocked down through the use of synthetic small RNA. Professor Lee’s team reported that synthetic small RNA can be employed for finely controlling the expression levels of multiple genes at the translation level. Already well-known for their systems metabolic engineering strategies, Professor Lee’s team added one more strategy to efficiently develop microbial cell factories for the production of chemicals and materials.
Here, we report the development of a general strategy for modulating gene expression at the translation stage using synthetic sRNAs that are rationally designed (rather than randomly screened), and we provide proof-of-concept applications to metabolic engineering by increasing the production of tyrosine and cadaverine in E. coli. The synthetic sRNA–based strategy reported here is advantageous over conventional gene-knockout strategies and other large-scale target identification strategies because of its easy implementation and because it does not rely on pre-constructed strain libraries.—Na et al.
Gene expression works like this: the hard-coded blueprint (DNA) is transcribed into messenger RNA (mRNA), and the coding information in mRNA is read to produce protein by ribosomes. Conventional genetic engineering approaches have often targeted modification of the blueprint itself (DNA) to alter organism’s physiological characteristics. Again, engineering the blueprint itself takes much time and effort, and in addition, the results obtained cannot be transferred to another organism without repeating the whole set of experiments.
Professor Lee and his colleagues aimed at controlling the gene expression level at the translation stage through the use of synthetic small RNA. They created novel RNAs that can regulate the translation of multiple messenger RNAs (mRNA), and consequently varying the expression levels of multiple genes at the same time. Briefly, synthetic regulatory RNAs interrupt gene expression process from DNA to protein by destroying the messenger RNAs to different yet controllable extents. The advantages of taking this strategy of employing synthetic small regulatory RNAs include simple, easy and high-throughput identification of gene knockout or knockdown targets, fine control of gene expression levels, transferability to many different host strains, and possibility of identifying those gene targets that are essential.
As proof-of-concept demonstration of the usefulness of this strategy, Professor Lee and his colleagues applied it to develop engineered E. coli strains capable of producing an aromatic amino acid tyrosine, which is used for stress symptom relief, food supplements, and precursor for many drugs. They examined a large number of genes in multiple E. coli strains, and developed a highly efficient tyrosine producer. Also, they were able to show that this strategy can be employed to an already metabolically engineered E. coli strain for further improvement by demonstrating the development of highly efficient producer of cadaverine, an important platform chemical for nylon in the chemical industry.
The design principles and the engineering strategy using synthetic sRNAs reported here are generalizable to other bacteria and applicable in developing superior producer strains. The ability to fine-tune target genes with designed sRNAs provides substantial advantages over gene-knockout strategies and other large-scale target identification strategies owing to its easy implementation, ability to modulate chromosomal gene expression without modifying those genes and because it does not require construction of strain libraries.—Na et al.
This new strategy, being simple yet very powerful for systems metabolic engineering, could facilitate the efficient development of microbial cell factories capable of producing chemicals, fuels and materials from renewable biomass.
This work was supported by the Technology Development Program to Solve Climate Changes on Systems Metabolic Engineering for Biorefineries (NRF-2012-C1AAA001-2012M1A2A2026556) and the Intelligent Synthetic Biology Center through the Global Frontier Project (2011-0031963) of the Ministry of Education, Science and Technology (MEST) through the National Research Foundation of Korea.
Dokyun Na, Seung Min Yoo, Hannah Chung, Hyegwon Park, Jin Hwan Park, and Sang Yup Lee (2013) Metabolic engineering of Escherichia coli using synthetic small regulatory RNAs. Nature Biotechnology doi: 10.1038/nbt.2461
TrackBack URL for this entry:
Listed below are links to weblogs that reference New metabolic engineering tool for microbial cell factories for chemicals, fuels and materials: